
The study by Fang-Hua Liu and his team from China Medical University, based on a systematic review of 51 meta-analyses, examined the link between blood group B and diabetes risk.
In a comprehensive study examining 270 health outcomes, researchers from China Medical University found that individuals with blood type B were 28% more likely to develop Type 2 diabetes than other groups.
AI-generated summary
The research was created by synthesizing 51 meta-analyzed systematic reviews to determine the effects of blood groups on susceptibility to chronic diseases.
In the world of epidemiology, diabetes, hematology and public health, remarkable scientific data has been shared regarding the effects of blood types on susceptibility to chronic diseases. Epidemiologist Fang-Hua Liu and his team from Shengjing Hospital of China Medical University conducted a massive data synthesis by examining 51 systematic reviews with meta-analyses published in the medical literature to date. In the study published in the journal BMC Medicine, possible relationships between blood groups and 270 different health outcomes were subjected to statistical stress tests.
270 DISEASE SCENARIOS ELIMINATED: THE ONLY EVIDENCE WAS IN BLOOD GROUP B
Scientists; He examined data covering thousands of cases in international databases such as PubMed, Web of Science, Embase and Scopus. After strict screening processes based on risks of bias, small sampling errors and reproducibility criteria, the only statistically definitive link between blood type and diseases was identified.
The data proved that individuals with B rh positive or B rh negative blood types were on average 28 percent more likely to develop Type 2 diabetes compared to those with blood types other than B (A, 0, AB).
NUTRITION AND LIFESTYLE ARE MUCH MORE CRITICAL THAN BLOOD TYPE
Researchers emphasize that the 28 percent increased risk detected in blood group B should not be ignored, but remains a secondary factor besides daily lifestyle factors.
According to medical data, consuming just 50 grams of processed meat a day increases the risk of Type 2 diabetes by 37 percent, while leading a sedentary life increases the risk by 112 percent. Obesity and overweight continue to be the key triggers in the development of diabetes.
THE GUT MICROBIOME AND BIOLOGICAL SHIELD ARE BEING INVESTIGATED
It is not yet fully understood how the antigens on the red blood cell surface, which determine the blood group, trigger diabetes. However, additional biochemistry studies conducted in 2025 and 2026 indicate that the intestinal microbiome structure of people with blood group B may affect insulin resistance.
Experts remind that blood group is an unchangeable biological parameter; He states that individuals with blood group B can completely eliminate this risk if they pay attention to their nutrition patterns, exercise routines and weight control.

Minister of Health Memişoğlu visited Samsung Medison, IFEZ and Celltrion in South Korea and examined the studies in the field of health technologies and biopharmaceuticals.

New accusations have emerged regarding the alleged reuse of disposable materials at Kahramanmaraş Sütçü İmam University Hospital. Health World Association President Hanifi Çöplü claimed that the doctor and nurse responsible for sterilization set up a front company through their relatives and sold the used products as new.

According to the 2026-TUS 2nd Term results announced by ÖSYM, quotas in pediatric surgery and child health branches remained largely empty. Experts drew attention to working conditions and malpractice pressure.

An international study conducted in England with 15.9 million participants revealed that untreated ADHD increases the risk of early death by 70%, while prescription medications significantly reduce this risk.

A new scientific study conducted in Canada revealed that the areas of cellular and vascular microdamage in the brains of individuals who consume most of their daily diet from ultra-processed foods are significantly increased.

Side effects such as nausea and fatigue experienced by patients using GLP-1 weight loss and diabetes drugs have created a billion-dollar food supplement market. Uncontrolled recommendations on social media are growing the industry.